choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:

Xarelto Newsletter
  • Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings Call Transcript 22 Jan 2026 13:28 GMT

    … treatment journey. DARZALEX is the largest medicine by sales in our pharmaceutical … drug revision system, which received its initial FDA … trials, we have significant momentum going into 2026. Johnson & Johnson … launch and what doctors and patients are …

  • Drugmakers hike prices in 2026: How much more will you… 18 Jan 2026 11:11 GMT

    … the COVID-19 vaccine to Ozempic despite … medications, including cancer drug Ibrance, migraine pill Nurtec and COVID-19 treatment … analysis. The drugs are Eliquis, Jardiance, Xarelto, Januvia, Farxiga … administration made with pharmaceutical companies don…

  • Ossoff-Backed Law Lowers Prices of 10 Prescription Drugs in 2026 15 Jan 2026 21:27 GMT

    … Ossoff that allows Medicare to negotiate directly with drug companies for … successfully empowered Medicare to lower prescription drug prices for seniors.” Drugs with Lower … Prices in 2026 Eliquis – blood clot prevention and treatment Xarelto …

  • Sen. Ossoff Helps Lower Prices of 10 Prescription Drugs in 2026 15 Jan 2026 02:47 GMT

    … forced drug companies to negotiate lower prescription drug costs with Medicare. Now, Medicare … of Medicare drug price negotiation: Eliquis for blood clot prevention & treatment … ulcerative colitis Xarelto for blood clot prevention & treatment # # …

  • JPM26: Bayer evades patent cliff in a way it may not be able to repeat 14 Jan 2026 21:17 GMT

    … , company’s head of pharmaceuticals, Stefan Oelrich, described its … by the exclusivity expiries of Xarelto (rivaroxaban) and Eylea ( … stage pipeline. Bayer lost its US patent on Xarelto, its … fresh US Food and Drug Administration (FDA) approval for advanced …

  • <![CDATA[JP Morgan 2026: Bayer’s Rejuvenated Portfolio ]]> 14 Jan 2026 00:45 GMT

    … key products such as Xarelto, Orick noted that Bayer has focused on … , addressing patients with limited treatment alternatives. Lynkuet, Bayer’s entry into non … , following the full impact of Xarelto’s loss of exclusivity in …

  • Bayer targets return to mid-single-digit pharma growth by 2027 13 Jan 2026 23:02 GMT

    … The pharmaceuticals and agriculture group Bayer aims to return its pharmaceuticals business … on its blood thinner Xarelto. Oelrich said in September … newer medicines, including prostate cancer treatment Nubeqa, kidney ‍drug Kerendia, heart medicine …

  • 1st Circuit: Trump admin can’t proceed with pilot drug rebate program 09 Jan 2026 16:41 GMT

    … Johnson & Johnson’s rival medication Xarelto; and Merck & Co’s diabetes drug … Januvia. Several of the medications … has required drugmakers seeking Medicaid and Medicare coverage for their drugs to …

  • Trump's health reform hits court hurdle, judge blocks drug rebate scheme for safety-net hospitals 08 Jan 2026 12:40 GMT

    … Johnson & Johnson’s rival medication Xarelto; and Merck & Co’s diabetes drug … Januvia. Several of the medications … has required drugmakers seeking Medicaid and Medicare coverage for their drugs to …

  • Trump administration cannot proceed with pilot drug rebate program, US court rules 08 Jan 2026 02:36 GMT

    … first 10 costly medications that are subject to Medicare drug price ‍negotiations … Johnson & Johnson’s rival medication Xarelto; and Merck & Co’s diabetes ​drug … has required drugmakers seeking Medicaid and Medicare coverage for their drugs to provide …

Satisfied with the content?

Continue to create your account.